Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,433 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prediction Model with HLA-A*33:03 Reveals Number of Days to Develop Liver Cancer from Blood Test.
Nishida N, Ohashi J, Suda G, Chiyoda T, Tamaki N, Tomiyama T, Ogasawara S, Sugiyama M, Kawai Y, Khor SS, Nagasaki M, Fujimoto A, Tsuchiura T, Ishikawa M, Matsuda K, Yano H, Yoshizumi T, Izumi N, Hasegawa K, Sakamoto N, Mizokami M, Tokunaga K. Nishida N, et al. Among authors: hasegawa k. Int J Mol Sci. 2023 Mar 1;24(5):4761. doi: 10.3390/ijms24054761. Int J Mol Sci. 2023. PMID: 36902191 Free PMC article.
Inclusion of tumor markers improves the correlation of the Milan criteria with vascular invasion and tumor cell differentiation in patients with hepatocellular carcinoma undergoing liver resection (#JGSU-D-07-00462).
Hasegawa K, Imamura H, Ijichi M, Matsuyama Y, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Hasegawa K, et al. J Gastrointest Surg. 2008 May;12(5):858-66. doi: 10.1007/s11605-007-0464-9. Epub 2008 Jan 18. J Gastrointest Surg. 2008. PMID: 18202893
Demonstration of quality of care measurement using the Japanese liver cancer registry.
Higashi T, Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Matsuyama Y, Sobue T; Liver Cancer Study Group of Japan. Higashi T, et al. Among authors: hasegawa k. Hepatol Res. 2011 Dec;41(12):1208-15. doi: 10.1111/j.1872-034X.2011.00880.x. Epub 2011 Oct 7. Hepatol Res. 2011. PMID: 21978019
Use of simeprevir following pre-emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12-week pilot study.
Tanaka T, Sugawara Y, Akamatsu N, Kaneko J, Tamura S, Aoki T, Sakamoto Y, Hasegawa K, Kurosaki M, Izumi N, Kokudo N. Tanaka T, et al. Among authors: hasegawa k. J Hepatobiliary Pancreat Sci. 2015 Feb;22(2):144-50. doi: 10.1002/jhbp.171. Epub 2014 Oct 22. J Hepatobiliary Pancreat Sci. 2015. PMID: 25338946
Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects.
Song P, Feng X, Inagaki Y, Song T, Zhang K, Wang Z, Zheng S, Ma K, Li Q, Kong D, Wu Q, Zhang T, Zhao X, Hasegawa K, Sugawara Y, Kokudo N, Tang W; Japan-China Joint Team for Medical Research and Cooperation on HCC. Song P, et al. Among authors: hasegawa k. Biosci Trends. 2014 Oct;8(5):266-73. doi: 10.5582/bst.2014.01116. Biosci Trends. 2014. PMID: 25382443 Free article.
4,433 results